Is Oncotype DX necessary in Mucinous Breast Carcinoma?

被引：0
|
作者：
Chang, Allison [1 ]
Singh, Kamaljeet [2 ]
Wang, Li Juan [3 ]
Yakirevich, Evgeny [4 ]
Witherby, Sabrina [5 ]
Wang, Yihong [1 ]
机构：
[1] Brown Univ, Rhode Isl Hosp, Providence, RI USA
[2] Women & Infants Hosp Rhode Isl, Providence, RI USA
[3] Lifespan, Providence, RI USA
[4] Rhode Isl Hosp, Providence, RI USA
[5] Brown Univ, Rhode Isl Hosp, Lifespan, Providence, RI USA
来源：
LABORATORY INVESTIGATION | 2024年 / 104卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
109
引用
收藏
页码：S130 / S130
页数：1
相关论文
共 50 条
  • [31] Oncotype DX Testing Does Not Benefit Patients with Low-Grade Breast Invasive Carcinoma
    Hou, Yanjun
    Zynger, Debra L.
    Li, Zaibo
    LABORATORY INVESTIGATION, 2017, 97 : 47A - 47A
  • [32] Ductal carcinoma in situ (DCIS) of the breast: miRNA deregulation correlates with the Oncotype DX risk score
    Loudig, Olivier
    Ben-Dov, Iddo
    Liu, Christina
    Komforti, Miglena
    Fineberg, Susan
    CANCER RESEARCH, 2020, 80 (04)
  • [33] How the Oncotype Dx Breast Cancer Assay for Ductal Carcinoma In Situ Impacts Treatment Decisions
    Cate, Sarah
    Cariseo, Elizabeth
    Chadha, Manjeet
    Gliedman, Paul
    Rescigno, John
    Gillego, Alyssa
    Radzio, Agnes
    Boolbol, Susan
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : 28 - 28
  • [34] Oncotype DX Testing Does Not Benefit Patients with Low-Grade Breast Invasive Carcinoma
    Hou, Yanjun
    Zynger, Debra L.
    Li, Zaibo
    MODERN PATHOLOGY, 2017, 30 : 47A - 47A
  • [35] Comparison of breast cancer prognostic tests CanAssist Breast and Oncotype DX
    Sengupta, Aditya K.
    Gunda, Aparna
    Malpani, Sukriti
    Serkad, Chandra Prakash, V
    Basavaraj, Chetana
    Bapat, Ashok
    Bakre, Manjiri M.
    CANCER MEDICINE, 2020, 9 (21): : 7810 - 7818
  • [36] Commentary on oncotype Dx
    Mehta, Prashant
    Batra, Atul
    Patel, Amol
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2019, 40 (03) : 434 - 434
  • [37] Current controversies in the use of Oncotype DX in early breast cancer
    Giachetti, Pier Paolo M. Berton
    Schianca, Ambra Carnevale
    Trapani, Dario
    Marra, Antonio
    Toss, Angela
    Marchio, Caterina
    Dieci, Maria Vittoria
    Gentilini, Oreste Davide
    Criscitiello, Carmen
    Kalinsky, Kevin
    Sparano, Joseph A.
    Curigliano, Giuseppe
    CANCER TREATMENT REVIEWS, 2025, 135
  • [38] Oncotype DX in Bilateral Synchronous Primary Invasive Breast Cancer
    Gunthner-Biller, M.
    Stempel, M.
    Patil, S.
    King, T.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S68 - S68
  • [39] Can Conventional Histopathologic Prognostic Parameters of Invasive Breast Carcinoma Predict the Oncotype DX™ Recurrence Score
    Bose, S.
    Mannan, A. A. S. R.
    Rathgeb, T.
    LABORATORY INVESTIGATION, 2011, 91 : 29A - 29A
  • [40] Triple Positive Breast Carcinomas: Is OncoType Dx™ Test Justified?
    Marchetti, E.
    Bhargava, R.
    Dabbs, D. J.
    MODERN PATHOLOGY, 2010, 23 : 61A - 62A
12345